JP2017511377A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017511377A5 JP2017511377A5 JP2017501145A JP2017501145A JP2017511377A5 JP 2017511377 A5 JP2017511377 A5 JP 2017511377A5 JP 2017501145 A JP2017501145 A JP 2017501145A JP 2017501145 A JP2017501145 A JP 2017501145A JP 2017511377 A5 JP2017511377 A5 JP 2017511377A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- compound
- disease
- compounds
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461968595P | 2014-03-21 | 2014-03-21 | |
| US61/968,595 | 2014-03-21 | ||
| PCT/US2015/022058 WO2015143447A2 (en) | 2014-03-21 | 2015-03-23 | Methods for treating neurological disorders |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019012873A Division JP2019065044A (ja) | 2014-03-21 | 2019-01-29 | 神経疾患を治療するための方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017511377A JP2017511377A (ja) | 2017-04-20 |
| JP2017511377A5 true JP2017511377A5 (enExample) | 2018-03-29 |
| JP6588962B2 JP6588962B2 (ja) | 2019-10-09 |
Family
ID=54145492
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017501145A Active JP6588962B2 (ja) | 2014-03-21 | 2015-03-23 | 神経疾患を治療するための方法 |
| JP2019012873A Withdrawn JP2019065044A (ja) | 2014-03-21 | 2019-01-29 | 神経疾患を治療するための方法 |
| JP2020066670A Withdrawn JP2020109123A (ja) | 2014-03-21 | 2020-04-02 | 神経疾患を治療するための方法 |
| JP2022131705A Pending JP2022159555A (ja) | 2014-03-21 | 2022-08-22 | 神経疾患を治療するための方法 |
| JP2024205572A Pending JP2025022992A (ja) | 2014-03-21 | 2024-11-26 | 神経疾患を治療するための方法 |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019012873A Withdrawn JP2019065044A (ja) | 2014-03-21 | 2019-01-29 | 神経疾患を治療するための方法 |
| JP2020066670A Withdrawn JP2020109123A (ja) | 2014-03-21 | 2020-04-02 | 神経疾患を治療するための方法 |
| JP2022131705A Pending JP2022159555A (ja) | 2014-03-21 | 2022-08-22 | 神経疾患を治療するための方法 |
| JP2024205572A Pending JP2025022992A (ja) | 2014-03-21 | 2024-11-26 | 神経疾患を治療するための方法 |
Country Status (19)
| Country | Link |
|---|---|
| US (3) | US10471029B2 (enExample) |
| EP (2) | EP4289820A3 (enExample) |
| JP (5) | JP6588962B2 (enExample) |
| KR (2) | KR102645633B1 (enExample) |
| CN (1) | CN106170563A (enExample) |
| AU (1) | AU2015230972B2 (enExample) |
| CA (1) | CA2941415A1 (enExample) |
| DK (1) | DK3119911T3 (enExample) |
| ES (1) | ES2960625T3 (enExample) |
| FI (1) | FI3119911T3 (enExample) |
| HR (1) | HRP20231172T1 (enExample) |
| HU (1) | HUE063369T2 (enExample) |
| LT (1) | LT3119911T (enExample) |
| PL (1) | PL3119911T3 (enExample) |
| PT (1) | PT3119911T (enExample) |
| RS (1) | RS64744B1 (enExample) |
| SI (1) | SI3119911T1 (enExample) |
| SM (1) | SMT202300369T1 (enExample) |
| WO (1) | WO2015143447A2 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT3347002T (pt) * | 2015-09-10 | 2023-07-27 | Alzheon Inc | Tratamento de doença de alzheimer numa população particular de pacientes |
| JP6704050B2 (ja) * | 2016-07-13 | 2020-06-03 | 株式会社マイトス | 水素を有効成分として含む軽度認知障害又は認知症の予防又は治療用組成物 |
| CN114805211B (zh) | 2017-03-21 | 2024-08-23 | 润佳（苏州）医药科技有限公司 | 同位素富集3-氨基-1-丙磺酸衍生物、药物组合物及其用途 |
| CN110003058B (zh) | 2018-01-04 | 2022-01-25 | 润佳（苏州）医药科技有限公司 | 3-((l-缬氨酰基)氨基)-3,3-二氘-1-丙磺酸晶型、制备方法及用途 |
| CN110668980A (zh) * | 2018-07-03 | 2020-01-10 | 浙江京新药业股份有限公司 | 一种2-取代的高牛磺酸衍生物 |
| DK3829563T3 (en) | 2018-08-01 | 2025-02-24 | Alzheon Inc | 3-sulfopropanoic acid for treating neurodegenerative disorders |
| AU2019314323B2 (en) * | 2018-08-01 | 2025-05-01 | Alzheon, Inc. | Sulfopropanoic acid derivatives for treating neurodegenerative disorders |
| CN111170901A (zh) * | 2018-11-13 | 2020-05-19 | 润佳（苏州）医药科技有限公司 | 3-((l-缬氨酰基)氨基)-1-丙磺酸晶型、制备方法及其用途 |
| JP2022536803A (ja) * | 2019-06-17 | 2022-08-18 | アルツェオン・インコーポレーテッド | 神経変性障害を治療する方法 |
| CN116059192B (zh) | 2019-11-13 | 2024-10-29 | 润佳（苏州）医药科技有限公司 | 同位素富集的3-氨基-1-丙磺酸及其衍生物的用途 |
| EP4514335A1 (en) * | 2022-04-28 | 2025-03-05 | Alzheon, Inc. | Tramiprosate for treating apoe4-related diseases |
| EP4626416A1 (en) | 2022-12-02 | 2025-10-08 | Alzheon, Inc. | Methods for treating neurodegenerative disorders with tramiprosate |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5698155A (en) | 1991-05-31 | 1997-12-16 | Gs Technologies, Inc. | Method for the manufacture of pharmaceutical cellulose capsules |
| WO1994009155A1 (en) * | 1992-10-13 | 1994-04-28 | Duke University | Methods of detecting alzheimer's disease |
| US20050031651A1 (en) | 2002-12-24 | 2005-02-10 | Francine Gervais | Therapeutic formulations for the treatment of beta-amyloid related diseases |
| US20060079578A1 (en) * | 2003-06-23 | 2006-04-13 | Julie Laurin | Pharmaceutical formulations of amyloid inhibiting compounds |
| US20070010573A1 (en) | 2003-06-23 | 2007-01-11 | Xianqi Kong | Methods and compositions for treating amyloid-related diseases |
| US20050142191A1 (en) | 2003-06-23 | 2005-06-30 | Neurochem (International) Limited | Pharmaceutical formulations of amyloid inhibiting compounds |
| WO2005060393A2 (en) | 2003-08-11 | 2005-07-07 | California Institute Of Technology | Microfluidic large scale integration |
| KR101608445B1 (ko) | 2006-10-12 | 2016-04-01 | 비에이치아이 리미티드 파트너쉽 | 3-아미노-1-프로판설폰산을 전달하기 위한 방법, 화합물, 조성물 및 비히클 |
| BRPI0719379A2 (pt) | 2006-11-24 | 2014-02-11 | Ac Immune Sa | Composto, composição farmacêutica, uso de composto, mistura, métodos para coletar dados para o diagnóstico de uma doença ou condição associada com amilóide em uma amostra ou um paciente, para determinar a extensão da carga de placa amiloidogênica em um tecido e/ou um fluido corporal, para coletar dados para determinar a predisposição a uma doença ou condição associada com amilóide em um paciente, para coletar dados para monitorar a doença residual mínima em um paciente seguindo o tratamento com um anticorpo ou uma composição de vacina e para coletar dados para predizer a responsividade de um paciente sendo tratado com um anticorpo ou uma composição de vacina, e, kit de teste |
| WO2012006329A2 (en) | 2010-07-06 | 2012-01-12 | Genomind, Llc | Apoe4 and apoj biomarker-based prevention and treatment of dementia |
| AU2011291506B2 (en) | 2010-08-19 | 2016-07-28 | Buck Institute For Age Research | Methods of treating mild cognitive impairment (mci) and related disorders |
| LT2994160T (lt) | 2013-05-06 | 2019-08-26 | Baxalta Incorporated | Alzheimerio ligos pogrupių gydymas su iš kelių donorų sumaišytu imunoglobulinu g |
| RU2724190C2 (ru) * | 2014-02-08 | 2020-06-23 | Дженентек, Инк. | Способы лечения болезни альцгеймера |
| PT3347002T (pt) | 2015-09-10 | 2023-07-27 | Alzheon Inc | Tratamento de doença de alzheimer numa população particular de pacientes |
| US20180250249A1 (en) | 2016-02-02 | 2018-09-06 | Alzheon, Inc. | Methods of treating neurodegenerative disorders in a particular population |
-
2015
- 2015-03-23 WO PCT/US2015/022058 patent/WO2015143447A2/en not_active Ceased
- 2015-03-23 DK DK15764560.7T patent/DK3119911T3/da active
- 2015-03-23 SM SM20230369T patent/SMT202300369T1/it unknown
- 2015-03-23 KR KR1020227033161A patent/KR102645633B1/ko active Active
- 2015-03-23 FI FIEP15764560.7T patent/FI3119911T3/fi active
- 2015-03-23 KR KR1020167027090A patent/KR102448386B1/ko active Active
- 2015-03-23 JP JP2017501145A patent/JP6588962B2/ja active Active
- 2015-03-23 HR HRP20231172TT patent/HRP20231172T1/hr unknown
- 2015-03-23 ES ES15764560T patent/ES2960625T3/es active Active
- 2015-03-23 SI SI201531967T patent/SI3119911T1/sl unknown
- 2015-03-23 PL PL15764560.7T patent/PL3119911T3/pl unknown
- 2015-03-23 US US15/127,565 patent/US10471029B2/en active Active
- 2015-03-23 CA CA2941415A patent/CA2941415A1/en active Pending
- 2015-03-23 PT PT157645607T patent/PT3119911T/pt unknown
- 2015-03-23 RS RS20230993A patent/RS64744B1/sr unknown
- 2015-03-23 LT LTEPPCT/US2015/022058T patent/LT3119911T/lt unknown
- 2015-03-23 EP EP23189240.7A patent/EP4289820A3/en active Pending
- 2015-03-23 CN CN201580015086.8A patent/CN106170563A/zh active Pending
- 2015-03-23 HU HUE15764560A patent/HUE063369T2/hu unknown
- 2015-03-23 AU AU2015230972A patent/AU2015230972B2/en active Active
- 2015-03-23 EP EP15764560.7A patent/EP3119911B1/en active Active
-
2019
- 2019-01-29 JP JP2019012873A patent/JP2019065044A/ja not_active Withdrawn
- 2019-09-13 US US16/570,487 patent/US20200101031A1/en not_active Abandoned
-
2020
- 2020-04-02 JP JP2020066670A patent/JP2020109123A/ja not_active Withdrawn
-
2022
- 2022-07-29 US US17/877,380 patent/US20230087041A1/en active Pending
- 2022-08-22 JP JP2022131705A patent/JP2022159555A/ja active Pending
-
2024
- 2024-11-26 JP JP2024205572A patent/JP2025022992A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019218375A5 (enExample) | ||
| JP2019516739A5 (enExample) | ||
| CY1119880T1 (el) | Παραγωγα πυρρολοπυριμιδινης για χρηση στη θεραπεια ιικων λοιμωξεων | |
| JP2016521119A5 (enExample) | ||
| JP2016536286A5 (enExample) | ||
| JP2016518337A5 (enExample) | ||
| JP2016516074A5 (enExample) | ||
| JP2014500861A5 (enExample) | ||
| JP2012504133A5 (enExample) | ||
| JP2017520613A5 (enExample) | ||
| JP2017528503A5 (enExample) | ||
| JP2017514910A5 (enExample) | ||
| JP2016539134A5 (enExample) | ||
| JP2016518328A5 (enExample) | ||
| JP2013507415A5 (enExample) | ||
| JP2015508103A5 (enExample) | ||
| JP2011518833A5 (enExample) | ||
| FI3119911T3 (fi) | Yhdisteitä käytettäväksi alzheimerin taudin hoitamisessa apoe4+/+-potilaissa | |
| JP2016522254A5 (enExample) | ||
| JP2019529514A5 (enExample) | ||
| JP2016539157A5 (enExample) | ||
| JP2016530265A5 (enExample) | ||
| JP2016510326A5 (enExample) | ||
| JP2010521516A5 (enExample) | ||
| JP2009501202A5 (enExample) |